The Effects of Ganciclovir and Valganciclovir Antiviral Treatments in Children with Congenital Cytomegalovirus Infection

Loading...
Thumbnail Image

Authors

Centola, Allyson

Issue Date

2016

Type

Presentation

Language

en_US

Keywords

congenital cytomegalovirus , antiviral treatments , ganciclovir , valganciclovir

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Congenital cytomegalovirus (cCMV) is one of the leading causes of non-hereditary newborn hearing losses. Typically children with a hearing loss would receive amplification to help combat the loss; however, new research has shown that children who have cCMV can receive antiviral treatments in lieu of amplification. Ganciclovir and valganciclovir are the antiviral treatments that are currently being used. These antiviral treatments help eliminate the viral load in the blood and thus improve the child’s hearing loss.

Description

Senior capstone poster, Department of Communication Sciences and Disorders, SUNY Plattsburgh

Citation

Publisher

License

Journal

Volume

Issue

PubMed ID

DOI

ISSN

EISSN